← Back
$LYRA All transactions

Lyra Therapeutics, Inc.

A

$ Value

$0

Shares

32,000

Price

$0

Filed

May 16

Insider

Name

MERRIFIELD C ANN

Title

CIK

0001247224

Roles

Director

Transaction Details

Transaction Date

2025-05-14

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,000

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan.

Filing Info

Accession No.

0000950170-25-073611

Form Type

4

Issuer CIK

0001327273

MERRIFIELD C ANN's History

Date Ticker Type Value
2025-05-14 LYRA A $0

Other Insiders at LYRA (90d)

Insider Bought Sold Last
Palasis Maria
Principal Executive Officer
2026-04-01
Cavalier Jason
Principal Financial Officer
2026-04-01